Quality Improvement for Institutions

Cardiovascular Quality and Research News

ACC CV Quality SmartBrief

The ACC CV Quality SmartBrief eNewsletter is a free, twice-weekly briefing for health care stakeholders interested in quality care. Learn more about the ACC CV Quality SmartBrief and subscribe.

  • Fungal pathogens developing resistance to treatment

    Aspergillus and Candida auris are developing drug resistance and becoming more difficult to treat, causing some patients to switch from one medication to the next and others to face the possibility of running out of treatment options. Data from the CDC indicate that C. auris infections increased eightfold in the US from 2017 to 2021, and the mortality rate is 30% to 60%, while aspergillosis cases rose 3% each year from 2000 to 2013 and cause more than 14,000 hospitalizations annually. NBC News (8/13) Learn More

  • Persistent symptoms found in youths hospitalized with COVID-19, MIS-C

    A study published in the journal Pediatrics found that more than one in four children who were hospitalized for acute COVID-19 or multisystem inflammatory syndrome in children had lingering symptoms or activity limitations for at least two months. The findings, based on a survey of 358 patients, also showed that patients who have MIS-C, respiratory issues or obesity were more likely to experience a protracted recovery. HealthDay News (8/12) Learn More

  • CDC: US COVID-19 cases down for 3rd week straight

    The US seven-day average for newly reported COVID-19 cases fell 13.8% to 103,614 as of Wednesday, marking the third consecutive week of decline, while the weekly average for COVID-19 deaths declined 6.7% to 400 from the prior week, according to the CDC. The seven-day average for COVID-19 hospitalizations fell 2.6% to 6,003 for the week ending Tuesday, and estimates suggest the Omicron BA.5 subvariant caused 88.8% of all US COVID-19 cases in the US for the week ending Saturday, while 39.6% of US communities had high levels of COVID-19 as of Thursday, down 2.1 percentage points from the week before. Becker's Hospital Review (8/12) Learn More

  • Homebound older adults increase Medicare spending

    Homebound older adults make up only 5.7% of the Medicare fee-for-service patient population but account for 11% of total Medicare fee-for-service spending, and they were more likely to have a potentially preventable hospitalization or an emergency room visit, according to a study published in the Journal of General Internal Medicine. Enhanced care for these patients such as telehealth could reduce costs, but lack of broadband access and support help, as well as sensory and cognitive impairments, can be barriers to telehealth, researchers wrote. HealthLeaders Media (8/15) Learn More

  • FDA approves use of Roche's flu drug for children

    The FDA has approved the expanded use of Roche's Xofluza to treat children ages 5 and older who have acute uncomplicated influenza and have been symptomatic for no more than 48 hours. The drug was also approved for preventing influenza in the same age group after exposure with an infected person. Reuters (8/12) Learn More

  • Researchers develop new molecular imaging method

    A team of researchers from the University of Southern California Viterbi School of Engineering's Department of Biomedical Engineering created a molecular imaging method that uses nanoparticles with gold cores to illuminate 26 unique biomarkers that can show cell behavior, according to a study published in the journal ACS Nano. "We're trying to offer physicians new functional imaging tools, rather than just structural imaging tools," said researcher Cristina Zavaleta. The research may have applications for diagnosing cancer, neurological disorders and viral infections. University of Southern California (8/11) Learn More

  • Cost info in heart drug ads doesn't sway patients

    Research published in JAMA Health Forum showed that people who viewed direct-to-consumer advertisements for heart medications were not more intent on switching drugs, looking them up online, viewing pharmaceutical companies more favorably, believing medication is effective for heart disease, or thinking that heart disease is a serious condition after price information was added to the ads. "These results are in line with the broader literature on price transparency in health care, which suggests that public information does not shift demand in appreciable ways," the researchers wrote. MedPage Today (free registration) (8/12) Learn More

Temp Styles

American College of Cardiology: 2400 N St. NW, Washington DC 20006